Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

TriMark Publications Announces the TriMark Cancer Biomarkers Conference 2008 in New York City on June 16th.

TriMark Publications Announces the TriMark Cancer Biomarkers Conference 2008 in New York City on June 16th.

The Conference will be held on Monday, June 16, 2008 at the Yale Club of New York City located at 50 Vanderbilt Avenue, New York City.

The TriMark Cancer Biomarker 2008 Conference has been organized to provide a critical examination of the latest in cancer diagnosis, as well as to provide insight from key industry leaders concerning cutting-edge technology platforms. This conference will also provide a forum for leaders in cancer biomarkers to share ideas, network with other delegates and advance understanding of the potential of new cancer detection technologies. The agenda will include:

Who should attend:

- Cancer diagnostics company representatives.
- In vitro diagnostic companies management and R&D directors.
- Biotechnology companies.
- Medical devices manufacturers.
- Diagnostic laboratory directors and staff.

Leaders from the following areas will greatly benefit from attending:

- Clinical Laboratory leaders.
- Hospital CFOs and CSOs.
- Physicians.
- Cancer diagnostics developers.
- Business development leaders.
- Strategic planning and development personnel.
- Technology development. 
- Marketing. 
- Research and development.

Key themes:

- A critical examination of key emerging biomarker technologies for cancer diagnostics. 
- Formation of successful alliances. 
- Application of emerging technologies to cancer diagnostics. 
- Transitioning from laboratory in vitro diagnostics to clinical management of cancer patients. 
- The emerging role of cancer diagnostic tests in personalized medicine.
- The intersection of genomics and cancer diagnostics with personalized medicine.

Questions answered in the TriMark conference:

- What will the cancer diagnostics market be worth by the end of the decade? 
- Which market key segments will drive cancer diagnostics market growth? 
- Which new technologies will reach the cancer diagnostics market in the next 2-3 years? 
- How is technology innovation impacting the dynamics and direction of the diagnostics industry? 
- How can clinical labs bring new cancer diagnostic tests to patent care?
- What are the key challenges in gaining acceptance of new technologies by users, payers and regulators? 
- How is technology innovation facilitating the transition of new cancer diagnostics testing into standard healthcare practice?

Top five reasons to attend the TriMark conference:

- Discover the cancer biomarkers sectors with the greatest prospective growth, ensuring you can successfully align your future strategies with predicted success. 
- Evaluate the competitive dynamics of the cancer biomarkers market and understand the changing relationship between IVD companies and the cancer diagnostics testing sector. 
- Identify the key players in the cancer biomarkers market, recognize lucrative partnering opportunities and benchmark your strategies against the leading players. 
- Assess opportunities and challenges faced by diagnostic companies in gaining acceptance of innovative technologies by payers, regulators and users. 
- Understand the factors driving growth of the cancer biomarkers market.

A full agenda of this event is available at the agenda homepage, or if you would like to register for the event, click here.